Instem PLC
LSE:INS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KOYJ Co Ltd
KOSDAQ:121850
|
KR |
|
Moleculin Biotech Inc
NASDAQ:MBRX
|
US |
|
C
|
Caixabank SA
SWB:48CA
|
ES |
|
Shenzhen Sunshine Laser & Electronics Technology Co Ltd
SZSE:300227
|
CN |
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| UK |
|
Instem PLC
LSE:INS
|
190m GBP |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
27.3B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.7B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
46.6B SEK |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.3B USD |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
4B USD |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.1B CNY |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
242.2B INR |
Loading...
|
Market Distribution
| Min | -188 120% |
| 30th Percentile | 0% |
| Median | 0% |
| 70th Percentile | 0.1% |
| Max | 10 443.9% |
Other Profitability Ratios
Instem PLC
Glance View
Instem Plc engages in the provision of information technology solutions and services to the global health and life sciences community. The company is headquartered in Stone, Staffordshire and currently employs 304 full-time employees. The company went IPO on 2010-10-13. The firm operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trials Acceleration. Its Study Management Solutions is a software that enables organizations to collect, review, manage and report discovery and preclinical report. Its Regulatory Solutions is a software, outsourced services and consultancy for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The firm's In Silico Solutions enables researchers to generate scientific insights through identification, extraction and analysis of information. Its Clinical Trials Acceleration Solutions is a technology solution and consulting service to facilitate data integration, statistics, analytics and insights for companies any size or stage of clinical trial analysis.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Instem PLC is 5.6%, which is in line with its 3-year median of 5.6%.
Over the last 2 years, Instem PLC’s Net Margin has increased from 5% to 5.6%. During this period, it reached a low of 3.7% on Dec 31, 2021 and a high of 8.2% on Dec 31, 2022.
